IDEXX Laboratories (IDXX) Competitors

IDEXX Laboratories (NASDAQ:IDXX) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, risk, valuation, dividends, earnings, profitability, media sentiment and institutional ownership.

Do analysts recommend IDXX or MDT?

IDEXX Laboratories presently has a consensus price target of $533.75, indicating a potential upside of 27.80%. Medtronic has a consensus price target of $96.07, indicating a potential upside of 8.56%. Given IDEXX Laboratories' stronger consensus rating and higher possible upside, analysts clearly believe IDEXX Laboratories is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.80
Medtronic	1 Sell rating(s)	8 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.44

Which has more volatility and risk, IDXX or MDT?

IDEXX Laboratories has a beta of 1.39, indicating that its share price is 39% more volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500.

Which has higher valuation and earnings, IDXX or MDT?

Medtronic has higher revenue and earnings than IDEXX Laboratories. Medtronic is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$3.90B	8.69	$887.87M	$10.67	39.14
Medtronic	$33.20B	3.42	$3.68B	$3.29	26.90

Does the MarketBeat Community favor IDXX or MDT?

Medtronic received 1052 more outperform votes than IDEXX Laboratories when rated by MarketBeat users. Likewise, 75.49% of users gave Medtronic an outperform vote while only 71.89% of users gave IDEXX Laboratories an outperform vote.

Company	Underperform	Outperform
IDEXX Laboratories	Outperform Votes 537 71.89%	Underperform Votes 210 28.11%
Medtronic	Outperform Votes 1589 75.49%	Underperform Votes 516 24.51%

Is IDXX or MDT more profitable?

IDEXX Laboratories has a net margin of 22.78% compared to Medtronic's net margin of 12.83%. IDEXX Laboratories' return on equity of 55.82% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	22.78%	55.82%	26.48%
Medtronic	12.83%	14.07%	7.70%

Does the media refer more to IDXX or MDT?

In the previous week, Medtronic had 29 more articles in the media than IDEXX Laboratories. MarketBeat recorded 54 mentions for Medtronic and 25 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.57 beat Medtronic's score of 1.14 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	22 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Medtronic	44 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Do insiders & institutionals have more ownership in IDXX or MDT?

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 2.1% of IDEXX Laboratories shares are owned by company insiders. Comparatively, 0.2% of Medtronic shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

IDEXX Laboratories beats Medtronic on 12 of the 17 factors compared between the two stocks.